HALAVEN 0.44 mg / ml solution for injection

Licence status
Authorised: 17/03/2011
Active substances
Eribulin mesylate
Dosage Form
Solution for injection
Licence number
EU/1/11/678/001-002
Licence holder
Eisai GmbH

Product documents

Licence information

ATC code
L01XX Other antineoplastic agents, L01XX41 eribulin
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
17/03/2011